Anne‐Katrin Güttsches

ORCID: 0000-0002-4017-940X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Muscle Physiology and Disorders
  • Genetic Neurodegenerative Diseases
  • Neurogenetic and Muscular Disorders Research
  • Cardiomyopathy and Myosin Studies
  • Advanced Neuroimaging Techniques and Applications
  • Inflammatory Myopathies and Dermatomyositis
  • Sports injuries and prevention
  • Hereditary Neurological Disorders
  • Cerebral Palsy and Movement Disorders
  • Stroke Rehabilitation and Recovery
  • Viral Infections and Immunology Research
  • Lysosomal Storage Disorders Research
  • Glycogen Storage Diseases and Myoclonus
  • Parkinson's Disease Mechanisms and Treatments
  • Virus-based gene therapy research
  • Prosthetics and Rehabilitation Robotics
  • RNA modifications and cancer
  • Botulinum Toxin and Related Neurological Disorders
  • Clinical Reasoning and Diagnostic Skills
  • Heterotopic Ossification and Related Conditions
  • Nuclear Structure and Function
  • Autoimmune and Inflammatory Disorders Research
  • Skin and Cellular Biology Research
  • Muscle and Compartmental Disorders
  • Neurological diseases and metabolism

BG University Hospital Bergmannsheil Bochum
2013-2024

Ruhr University Bochum
2011-2024

Sporadic inclusion body myositis (sIBM) pathogenesis is unknown; however, rimmed vacuoles (RVs) are a constant feature. We propose to identify proteins that accumulate within RVs.RVs and intact myofibers were laser microdissected from skeletal muscle of 18 sIBM patients analyzed by sensitive mass spectrometry approach using label-free spectral count-based relative protein quantification. Whole exome sequencing was performed on 62 patients. Immunofluorescence patient mouse muscle.A total 213...

10.1002/ana.24847 article EN Annals of Neurology 2016-12-25
Astrid Pechmann Max Behrens Katharina Dörnbrack Adrian Tassoni Franziska Wenzel and 95 more Sabine Stein Sibylle Emilie Vogt Daniela Zöller G. Bernert Tim Hagenacker Ulrike Schara‐Schmidt Maggie C. Walter Astrid Bertsche Katharina Vill Matthias Baumann Manuela Baumgärtner Isabell Cordts Astrid Eisenkölbl Marina Flotats‐Bastardas Johannes Friese René Günther Andreas Hahn Veronka Horber Ralf A. Husain Sabine Illsinger Jörg Jahnel Jessika Johannsen Cornelia Köhler Heike Kölbel Monika Müller Arpad von Moers Annette Schwerin-Nagel Christof Reihle Kurt Schlachter Gudrun Schreiber Oliver Schwartz Martin Smitka Elisabeth Steiner Regina Trollmann Markus Weiler Claudia Weiß Gert Wiegand Ekkehard Wilichowski Andreas Ziegler Hanns Lochmüller Janbernd Kirschner Lisa Ameshofer Bárbara Andres Daniela Angelova-Toshkina Daniela Banholzer Christina Bant Petra Baum Sandra Baumann Ute Baur Benedikt Becker Bettina Behring Julia Bellut Andrea Bevot Jasmin Bischofberger Lisa Bitzan Bogdan Bjelica Markus Blankenburg Sandra Böger Friederike Bonetti Anke Bongartz Svenja Brakemeier Lisa Bratka Nathalie Braun Sarah Braun Brigitte Brauner Christa Bretschneider Nadine Burgenmeister Bea Burke Sebahattin Çırak Andrea Dall Heike de Vries Adela Della Marina Jonas Denecke Marcus Deschauer Zylfie Dibrani Uta Diebold Lutz Dondit Jessica Drebes Joenna Driemeyer Vladimir Dukic Matthias Eckenweiler Mirjam Eminger Michal Fischer Cornelia Fischer Maren Freigang Philippa Gaiser Andrea Gangfuß Stephanie Geitmann Annette George Magdalena Gosk-Tomek Susanne Grinzinger Kristina Gröning Martin Groß Anne‐Katrin Güttsches Anna Hagenmeyer

Abstract Background The development and approval of disease modifying treatments have dramatically changed progression in patients with spinal muscular atrophy (SMA). Nusinersen was approved Europe 2017 for the treatment SMA irrespective age severity. Most data on therapeutic efficacy are available infantile-onset SMA. For type 2 3, there is still a lack sufficient evidence long-term experience nusinersen treatment. Here, we report from SMArtCARE registry non-ambulant children typen 3 under...

10.1186/s13023-022-02547-8 article EN cc-by Orphanet Journal of Rare Diseases 2022-10-23

Purpose: Exoskeletons have been developed for rehabilitation of patients with walking impairment due to neurological disorders. Recent studies shown that the voluntary-driven exoskeleton HAL® (hybrid assistive limb) can improve functions in spinal cord injury and stroke. The aim this study was assess safety effects on function supported treadmill therapy limb-girdle muscular dystrophy (LGMD). Materials Methods: Three LGMD received 8 weeks training 3 times a week. Outcome parameters were...

10.3389/fnins.2017.00449 article EN cc-by Frontiers in Neuroscience 2017-08-08

Duchenne muscular dystrophy (DMD) is a severe progressive muscle disease that mainly affects boys due to X-linked recessive inheritance. In most affected individuals, MLPA or sequencing-based techniques detect deletions, duplications, point mutations in the dystrophin-encoding DMD gene. However, small subset of patients clinically diagnosed with DMD, molecular cause not identified these routine methods. Evaluation 60 our center revealed three cases without known genetic cause. DNA samples...

10.3390/ijms241914716 article EN International Journal of Molecular Sciences 2023-09-28

Escherichia coli Nissle 1917 (EcN) bears a defect in its LPS biosynthesis leading to truncated variable oligosaccharide-antigen chains and semi-rough phenotype. It is effectively inactivated by complement factors due resolved serum resistance is, therefore, safe as probiotic strain, i.e. for the treatment of inflammatory gastrointestinal diseases. unknown whether modification EcN contributes properties. Purified from wild-type uropathogenic E. W536 together with raw lysates both strains were...

10.1177/1753425910396251 article EN Innate Immunity 2011-03-07

Skeletal muscle biopsy is one of the gold standards in diagnostic workup disorders. By histopathologic analysis, characteristic features like inflammatory cellular infiltrations, fat and collagen replacement tissue or structural defects myofibers can be detected. In past years, novel quantitative MRI (qMRI) techniques have been developed to quantify parameters, thus providing a non-invasive tool several myopathies.This proof-of-principle study was performed validate qMRI-techniques skeletal...

10.3233/jnd-210641 article EN Journal of Neuromuscular Diseases 2021-03-30

Abstract Quantitative muscle magnetic resonance imaging (qMRI) is a valuable methodology for assessing muscular injuries and neuromuscular disorders. Notably, diffusion tensor (DTI) gives insights into microstructural macrostructural characteristics. However, the long‐term reproducibility robustness of these measurements remain relatively unexplored. The purpose this prospective longitudinal cohort study was to assess range variation qMRI parameters, especially DTI metrics, in lower...

10.1002/nbm.5214 article EN cc-by-nc NMR in Biomedicine 2024-07-10

Sporadic inclusion body myositis (sIBM) is the predominant idiopathic inflammatory myopathy (IIM) in older people. Limitations of classical clinical assessments have been discussed as possible explanations for failed trials, underlining need more sensitive outcome measures. Quantitative muscle MRI (qMRI) a promising candidate evaluating and monitoring sIBM.

10.3233/jnd-240053 article EN Journal of Neuromuscular Diseases 2024-07-19

Abstract Background and purpose Quantitative muscle magnetic resonance imaging (MRI) is a promising non‐invasive method in the diagnostic workup as well follow‐up of neuromuscular disorders. The aim this study was to correlate quantitative MRI (qMRI) parameters histopathological changes skeletal tissue thus verify data from our pilot study. Methods Twenty‐six patients (eight females, 46.4 ± 15.1 years) were examined within 72 h before 24 after biopsy using MRI. Post‐biopsy employed pinpoint...

10.1111/ene.16479 article EN cc-by European Journal of Neurology 2024-09-16

Diagnosis of neuromuscular diseases in primary care is often challenging. Rare such as Pompe disease are easily overlooked by the general practitioner. We therefore aimed to develop a diagnostic support tool using patient-oriented questions and combined data mining algorithms recognizing answer patterns individuals with selected diseases. A multicenter prospective study for proof concept was conducted thereafter. First, 16 interviews patients were focusing on their pre-diagnostic...

10.1186/s12911-016-0268-5 article EN cc-by BMC Medical Informatics and Decision Making 2016-03-08

Abstract To evaluate differences in qMRI parameters of muscle diffusion tensor imaging (mDTI), fat-fraction (FF) and water T2 time leg muscles calpainopathy patients (LGMD R1/D4) compared to healthy controls, correlate those findings clinical if show degeneration not-yet fatty infiltrated muscles. We evaluated eight thigh seven calf 19 matched controls. MRI scans were performed on a 3T including mDTI, mapping mDixonquant sequence. Clinical assessment was done with manual testing, patient...

10.1038/s41598-022-23972-6 article EN cc-by Scientific Reports 2022-11-16

Bi-allelic variants in VWA1, encoding Von Willebrand Factor A domain containing 1 protein localized to the extracellular matrix (ECM), were linked a neuromuscular disorder with manifestation child- or adulthood. Clinical findings indicate neuromyopathy presenting muscle weakness. Given that pathophysiological processes are still incompletely understood, and biomarkers missing, we aimed identify blood of relevance: white cells (WBC) plasma derived from six VWA1-patients investigated by...

10.1111/jcmm.18122 article EN cc-by Journal of Cellular and Molecular Medicine 2024-04-01

Late-onset Pompe disease (LOPD) is a metabolic myopathy caused by mutations in GAA and characterized proximal muscle weakness respiratory insufficiency. There evidence from clinical studies that enzyme replacement therapy (ERT) with human recombinant alpha-glucosidase improves motor performance function LOPD.We analyzed quantitative MRI data of lower limbs to evaluate the effects long-term ERT on parameters.Three symptomatic LOPD patients who received for five years four untreated...

10.1016/j.ymgmr.2015.03.010 article EN cc-by-nc-nd Molecular Genetics and Metabolism Reports 2015-04-21

High pre-existing antibodies against viral vectors reduce their functionality and may lead to adverse complications. To circumvent this problem in future gene therapy approaches, we tested the seroprevalence of a large range human adenovirus types patients with neuromuscular disorders (NMDs) find appropriate vector candidates for replacement NMDs. Binding neutralizing 39 were sera 133 NMDs 76 healthy controls aged 17–92 years. The influence age, sex, on antibody levels was analyzed....

10.3390/v15010079 article EN cc-by Viruses 2022-12-27

Pain occurs in the majority of patients with late onset Pompe disease (LOPD) and is associated a reduced quality life. The aim this study was to analyse pain characteristics its relation small nerve fiber involvement LOPD patients.In 35 under enzyme replacement therapy without clinical signs polyneuropathy (19 females; 51 ± 15 years), as well depressive anxiety symptoms were assessed using PainDetect questionnaire (PDQ) hospital depression scale (HADS), respectively. Distal skin biopsies...

10.1186/s13023-022-02327-4 article EN cc-by Orphanet Journal of Rare Diseases 2022-04-27

Background: Quantitative muscle MRI (qMRI) is a promising tool for evaluating and monitoring neuromuscular disorders (NMD). However, the application of different imaging protocols processing pipelines restricts comparison between patient cohorts disorders. In this qMRI study, we aim to compare dystrophic (limb-girdle muscular dystrophy), inflammatory (inclusion body myositis), metabolic myopathy (Pompe disease) as well patients with post-COVID-19 conditions suffering from myalgia healthy...

10.3390/jcm13071958 article EN Journal of Clinical Medicine 2024-03-28

Limb-girdle muscular dystrophy (LGMD) type R1 (LGMDR1) is the most common subtype of LGMD in Europe. Prospective longitudinal data, including clinical assessments and new biomarkers such as quantitative magnetic resonance imaging (qMRI), are needed to evaluate natural course disease therapeutic options. We evaluated eight thigh seven leg muscles 13 LGMDR1 patients (seven females, mean age 36.7 years, body mass index 23.9 kg/m

10.1002/nbm.5172 article EN cc-by-nc NMR in Biomedicine 2024-05-25

High levels of pre-existing antibodies are a major challenge for the application viral vectors since they can severely limit their efficacy. To identify promising candidates among adeno-associated virus (AAV) based future gene therapies treatment hereditary neuromuscular disorders (NMDs), we investigated antibody in sera from patients with NMDs against 18 AAV types, including 11 AAVs wild-type capsids, 5 peptide-modified capsids and 2 shuffled capsids. With regard to capsid AAVs, lowest...

10.3389/fimmu.2024.1450858 article EN cc-by Frontiers in Immunology 2024-09-27

Myotonic Dystrophies type 1 and 2 are hereditary myopathies with dystrophic muscle degeneration in varying degrees. Differences diffusion between both diseases have not been evaluated yet.To evaluate the ability of tensor imaging (mDTI) Dixon fat-quantification to distinguish Dystrophy (DM) if show distinct involvement patterns.We 6 thigh 7 calf muscles (both legs) 10 DM 1, 13 28 healthy controls (HC) imaging, T1w mDixonquant sequences a 3T MRI scanner. The quantitative mDTI-values axial...

10.3233/jnd-210660 article EN Journal of Neuromuscular Diseases 2021-06-22

Muscle diffusion tensor imaging (mDTI)-based tractography is a promising tool with which to detect subclinical changes in muscle injuries and evaluate pathophysiology neuromuscular diseases. Classic region of interest (ROI)-based very time-consuming requires an examiner extensive experience. (Semi)automatic approaches such as volume-based (VBT) can diminish this problem but its robustness stability are unknown. The aim the current study was assess performance VBT multicenter setting...

10.1002/nbm.4707 article EN cc-by-nc NMR in Biomedicine 2022-02-01

Here we introduce the human induced pluripotent stem cell (hiPSC) line HIMRi001-A generated from cultured dermal fibroblasts of a 60-year-old male patient with myofibrillar myopathy, carrying heterozygous c.4984C > T [p.Q1662X] mutation in filamin C (FLNC)-gene, via lentiviral expression OCT4, SOX2, KLF4 and c-MYC. displays typical embryonic cell-like morphology, carries FLNC gene mutation, expressed several makers, retained normal karyotype (46, XY) holds potential to differentiate all...

10.1016/j.scr.2023.103210 article EN cc-by Stem Cell Research 2023-09-21

Sporadic inclusion body myositis (sIBM) is characterized by myopathological features including rimmed vacuoles (RVs) and proteins associated with protein aggregation, autophagy, inflammation. Previous proteomic studies of RV areas revealed an overrepresentation several chaperones subunits the T-complex 1 (TCP-1), which involved in prevention aggregation.To validate our findings, immunofluorescence analyses selected quantitative Western blot analysis TCP-1 were performed five sIBM patients...

10.1002/mus.26742 article EN cc-by-nc-nd Muscle & Nerve 2019-10-23

Sporadic inclusion body myositis (sIBM) and polymyositis (PM) are characterized by muscle inflammation, with sIBM showing additional degenerative alterations. In this study we investigated human beta defensins associated TLRs to elucidate the role of innate immune system in idiopathic inflammatory myopathies (IIM), its association Expression levels beta-defensin (HBD)-1, HBD-2, HBD-3 TLR2, 3, 4, 7 9 were analysed quantitative real-time PCR skeletal tissue. Localization HBD-3, collagen 6,...

10.1177/1753425913481820 article EN Innate Immunity 2013-04-22
Coming Soon ...